These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 17532158)

  • 1. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.
    Santos RG; Landeira-Fernandez J; Strassman RJ; Motta V; Cruz AP
    J Ethnopharmacol; 2007 Jul; 112(3):507-13. PubMed ID: 17532158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The globalization of ayahuasca: harm reduction or benefit maximization?
    Tupper KW
    Int J Drug Policy; 2008 Aug; 19(4):297-303. PubMed ID: 18638702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage.
    Gambelunghe C; Aroni K; Rossi R; Moretti L; Bacci M
    Biomed Chromatogr; 2008 Oct; 22(10):1056-9. PubMed ID: 18506697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay.
    Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A
    Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
    Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
    J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
    McKenna DJ
    Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament.
    Halpern JH; Sherwood AR; Passie T; Blackwell KC; Ruttenber AJ
    Med Sci Monit; 2008 Aug; 14(8):SR15-22. PubMed ID: 18668010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage.
    Pires AP; De Oliveira CD; Moura S; Dörr FA; Silva WA; Yonamine M
    Phytochem Anal; 2009; 20(2):149-53. PubMed ID: 19140116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
    Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ
    J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Various alkaloid profiles in decoctions of Banisteriopsis caapi.
    Callaway JC
    J Psychoactive Drugs; 2005 Jun; 37(2):151-5. PubMed ID: 16149328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical Composition of Traditional and Analog Ayahuasca.
    Kaasik H; Souza RCZ; Zandonadi FS; Tófoli LF; Sussulini A
    J Psychoactive Drugs; 2021; 53(1):65-75. PubMed ID: 32896230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
    Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
    Hamill J; Hallak J; Dursun SM; Baker G
    Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health status of ayahuasca users.
    Barbosa PC; Mizumoto S; Bogenschutz MP; Strassman RJ
    Drug Test Anal; 2012; 4(7-8):601-9. PubMed ID: 22761152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies.
    Dos Santos RG; Osório FL; Crippa JA; Hallak JE
    Braz J Psychiatry; 2016 Mar; 38(1):65-72. PubMed ID: 27111702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users.
    Ramaekers JG; Mallaroni P; Kloft L; Reckweg JT; Toennes SW; van Oorsouw K; Mason NL
    J Cogn Neurosci; 2023 Sep; 35(9):1382-1393. PubMed ID: 37159257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.
    Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ
    Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges.
    Labate BC; Feeney K
    Int J Drug Policy; 2012 Mar; 23(2):154-61. PubMed ID: 21856141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ayahuasca Alters Structural Parameters of the Rat Aorta.
    Pitol DL; Siéssere S; Dos Santos RG; Rosa ML; Hallak JE; Scalize PH; Pereira BF; Iyomasa MM; Semprini M; Riba J; Regalo SC
    J Cardiovasc Pharmacol; 2015 Jul; 66(1):58-62. PubMed ID: 25714595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society.
    Blainey MG
    J Relig Health; 2015 Feb; 54(1):287-302. PubMed ID: 24477460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.